​

Funding Round

Series A - Ablaze Pharmaceuticals

Series A - Ablaze Pharmaceuticals

Investment Firm

Overview

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.

Announced Date

Nov 29, 2021

Closed on Date

Nov 29, 2021

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

Vivo Capital

Vivo Capital

Vivo Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Advantech Capital

Advantech Capital

Advantech Capital is a early_stage_venture and late_stage_venture firm.

Participant Investors

3

Investor Name
Participant InvestorAdvantech Capital
Participant InvestorvenBio Partners
Participant InvestorVivo Capital

Round Details and Background

Ablaze Pharmaceuticals raised $75000000 on 2021-11-29 in Series A

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 29, 2021
Series A - Ablaze Pharmaceuticals
8-75.0M

Recent Activity

There is no recent news or activity for this profile.